Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

All statements other than statements of historical facts contained in this release, including statements regarding the timing of our clinical trials, our strategy, future operations, future financial ...

Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to resume Q2 2025 Strengthens commercial leadership with appo ...

TIFR uncover harmful effects of sugar beverages on health, proposing targeted therapies for metabolic effects from ...

Researchers at the Advanced Research Unit on Metabolism, Development & Aging (ARUMDA), in the Tata Institute of Fundamental Research (TIFR, Mumbai and ...

The Artisan International Small-Mid Fund portfolio outperformed the MSCI ACWI ex USA SMID Index in Q4 of 2024. Click here to ...

WireDaily.com has released a new Gluco Extend Reviews report for 2025. CHICAGO HEIGHTS, IL / ACCESS Newswire / March 21, 2025 / WireDaily is proud to announce the release of its Gluco Extend Reviews ...

Discover the truth about Sugar Defender reviews and whether it really works or if it's just another Sugar Defender scam.